iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Up 1.1%

Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) were up 1.1% on Tuesday . The company traded as high as $64.08 and last traded at $63.92. Approximately 16,032 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 71,795 shares. The stock had previously closed at $63.25.

iShares U.S. Pharmaceuticals ETF Stock Performance

The firm has a market capitalization of $645.59 million, a P/E ratio of 6.23 and a beta of 0.59. The stock has a 50 day moving average of $66.90 and a two-hundred day moving average of $62.83.

Hedge Funds Weigh In On iShares U.S. Pharmaceuticals ETF

A number of institutional investors have recently modified their holdings of the company. Capital Investment Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $235,000. Bruce G. Allen Investments LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at about $233,000. Trust Co. of Vermont bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the third quarter worth about $107,000. PNC Financial Services Group Inc. lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 28.8% during the 3rd quarter. PNC Financial Services Group Inc. now owns 434 shares of the company’s stock worth $77,000 after purchasing an additional 97 shares during the last quarter. Finally, HighTower Advisors LLC boosted its stake in iShares U.S. Pharmaceuticals ETF by 36.5% during the 3rd quarter. HighTower Advisors LLC now owns 1,941 shares of the company’s stock valued at $343,000 after purchasing an additional 519 shares during the period.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.